Mianserin versus amitriptyline. A double-blind-trial evaluated by the AMP system. 1976

H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher

Amitriptyline and mianserin were compared in a double-blind trial. Most of the depressive symptoms were influenced by both drugs, though quantitative and qualitative differences became evident. Amitriptyline predominantly influenced anxiety, despair and suicidal tendencies, while mianserin was particularly effective in psychomotor inhibition and the reduction of vegitative complaints. Mianserin did not show anticholinergic side effects.

UI MeSH Term Description Entries
D008803 Mianserin A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors. Lerivon,Mianserin Hydrochloride,Mianserin Monohydrochloride,Org GB 94,Tolvon,Hydrochloride, Mianserin,Monohydrochloride, Mianserin
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000639 Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. Amineurin,Amitrip,Amitriptylin Beta,Amitriptylin Desitin,Amitriptylin RPh,Amitriptylin-Neuraxpharm,Amitriptyline Hydrochloride,Amitrol,Anapsique,Apo-Amitriptyline,Damilen,Domical,Elavil,Endep,Laroxyl,Lentizol,Novoprotect,Saroten,Sarotex,Syneudon,Triptafen,Tryptanol,Tryptine,Tryptizol,Amitriptylin Neuraxpharm,Apo Amitriptyline,Desitin, Amitriptylin,RPh, Amitriptylin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher
January 1984, Neuropsychobiology,
H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher
January 1983, Pharmacotherapy,
H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher
January 1980, Current medical research and opinion,
H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher
January 1988, Psychopharmacology,
H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher
July 1985, Acta psychiatrica Scandinavica,
H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher
January 1983, British journal of clinical pharmacology,
H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher
January 1982, Advances in biochemical psychopharmacology,
H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher
January 1992, Pain,
H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher
August 1994, Journal of clinical psychopharmacology,
H P Vogel, and D Bente, and J Feder, and H Helmchen, and B Müller-Oerlinghausen, and N Bohacek, and M Mihovilović, and A Brändli, and J Fleischhauer, and W Walcher
January 1978, British journal of clinical pharmacology,
Copied contents to your clipboard!